1. The Chief Medical Officer or a qualified person designated by the Administrator of the Division shall analyze the information obtained pursuant to NRS 439.4929, 439.4931 and 439.4933 and the reports published pursuant to NRS 439.4935 to determine whether any trends exist in the usage of and access to health care services by patients with sickle cell disease and its variants in a particular area or population.
2. If the Chief Medical Officer or the person designated pursuant to subsection 1 determines that a trend exists in the usage of and access to health care services by patients with sickle cell disease and its variants in a particular area or population, the Chief Medical Officer or the person designated pursuant to subsection 1 shall work with appropriate governmental, educational and research entities to investigate the trend, advance research in the trend and facilitate the treatment of sickle cell disease and its variants and associated disorders.
(Added to NRS by 2019, 2160)